---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/41475127.md"
description: "Moderna rose by seven or eight percentage points, one of the top gainers in U.S. biotech stocks today, as expectations for its vaccine pipeline were revived by capital; Revolution Medicines and BlueJay Diagnostics both rose by three or four percentage points, with small catalysts for oncology drugs and diagnostics respectively. 😸Summit rose slightly, while Legend Biotech fell slightly. Amid market volatility, biotech has instead become a safe haven. This batch lacks a unified sector logic and is more like capital rotating among stocks with stories and data expectations during a broad decline."
datetime: "2026-06-04T10:52:20.000Z"
locales:
  - [en](https://longbridge.com/en/topics/41475127.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/41475127.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/41475127.md)
author: "[小仓位过过日子](https://longbridge.com/en/profiles/27571747.md)"
---

# Moderna rose by seven or eight percentage points, …


### Related Stocks

- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)
- [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)